Clinical Trial Update: A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ocrelizumab versus placebo in rheumatoid arthritis patients with inadequate response to methotrexate was terminated with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: TERMINATED | Results posted: 2020-12-04